Document ID: chunk:federal_register_of_legislation:C2010A00126:clause:4_99adj:p4
Version: federal_register_of_legislation:C2010A00126
Segment Type: clause
Provision Reference: sch 4 cl 99ADJ (pt 4/4)
Character Range: 43647–44471

for the purposes of:
 (a) working out under subsection (3) the average unadjusted price reduction for all the brands of pharmaceutical items to which this section applies; and
 (b) working out under subsection (6) the adjusted approved ex‑manufacturer price of the brand.

The weighted average disclosed price of a brand
 (9) Until the Minister determines the weighted average disclosed price of a brand of a pharmaceutical item in respect of the period of 10 months ending on 30 September 2011, that weighted average disclosed price is taken, for the purposes of any reference in this section to:
 (a) the applicable approved ex‑manufacturer price of the brand; or
 (b) the unadjusted price reduction for the brand;
to be the price worked out in accordance with the regulations made for the purposes of subsection 99ADB(6).